Rosh Dias

Dr. Dias has more than more than 20 years of pharmaceutical and biotechnology industry experience leading United States and global teams in clinical development and medical affairs across multiple disease areas including oncology, cardiometabolic health and rare diseases. Prior to joining Coherus he was the Chief Medical Officer at Spruce Biosciences, where he oversaw global clinical development and strategy. Prior to Spruce, Dr. Dias served as Chief Medical Officer at Indivior PLC, a global commercial pharmaceutical company focused on substance abuse and other serious mental disorders. From 2014 to 2018, Dr. Dias held senior leadership positions at Amgen, most recently as Vice President, Global Scientific Affairs, and at Amgen’s subsidiary, Onxy Pharmaceuticals, as Head of Global Medical and Scientific Affairs. Prior to Onyx, Dr. Dias worked for 10 years at Novartis Oncology in roles of increasing responsibility, including leadership roles in the global organization, the United States and in Australia, where he directed clinical development and medical affairs efforts with a focus on oncology, hematology and rare diseases.

Dr. Dias holds a Medical Doctor degree from Charing Cross and Westminster Medical School in the UK, and is a Member of the Royal College of Physicians through postgraduate qualification in Internal Medicine.